November 22, 2019
There are few clinical areas more in need of innovation than heart disease. It’s the leading killer among men and women in the US, accounting for one in every four deaths by the CDC’s numbers, and yet it’s also a body of health conditions that could be substantially mitigated through a number of lifestyle and behavior changes.
So of course it’s little surprise that cardiovascular health and care...
November 15, 2019
Livongo is touting new data regarding the efficacy of its device-and-coaching disease management platform, this time among those using its Livongo for Hypertension and Livongo for Diabetes products together.
The results, which are set to be formally presented this weekend at the American Heart Association Scientific Sessions 2019, identified significant decreases in hypertensive blood pressure as...
October 11, 2019
It’s little secret that chronic conditions are a heavy burden on the healthcare system. Diabetes, heart disease, obesity and others can stick with a patient for decades, often leading to increased spending on disease management programs and costly visits when those efforts aren’t making an impact.
What’s worse, many of the clinical advances of the past decade or so haven’t substantially moved the...
October 10, 2019
Digital chronic disease management company Omada Health has added onto June’s $73 million funding round with a new strategic investment from Intermountain Ventures. The terms of the deal were not disclosed.
WHAT THEY DO
Omada pitches its digital coaching programs as a scalable and convenient approach to chronic disease management. The company’s products address hypertension, Type 2 diabetes,...
September 18, 2019
Digital diabetes and chronic care company OneDrop has landed $40 million in a Series B funding round led by pharma giant Bayer. This news coincides with the announcement that Bayer inked a deal with the startup, entering into a commercial licensing agreement to use OneDrop’s platform.
This isn’t Bayer’s first foray into digital health. The company has its own accelerator in Germany that was...
July 31, 2019
Hello Heart, maker of a digital chronic disease health program for employees, has raised $12 million in Series B funding. The round was led by Khosla Ventures, with additional support from previous backers BlueRun Ventures, Maven Ventures and Resolute Ventures.
WHAT THEY DO
Hello Heart’s bread and butter is its app-driven platform for hypertension, blood pressure and general cardiovascular health...
July 29, 2019
After much speculation and anticipation, chronic care management startup Livongo officially went public on Thursday. The company closed its first day 36% above its initial pricing of $28 and is currently trading for over $41 per share on NASDAQ. The company's includes more than 12 million shares of common stock.
“It’s a signal to the market ... that [the industry] is ready for a consumer-first...
June 28, 2019
Months after the first rumors began to swirl, chronic disease management startup Livongo Health has officially filed for an IPO on the Nasdaq Global Select Market.
The company has not yet determined a price range or the number of shares going on offer. Morgan Stanley & Co., Goldman Sachs & Co. and JP Morgan Securities will serve as the lead book runners.
Sources close to Livongo told...
June 26, 2019
Digital chronic disease management startup Livongo is making the jump from patients’ pockets to their wrists with new integrations that will bring some of the mobile app’s alerts and features to consumer smartwatches.
Starting today, certain models of Apple Watches, Fitbits and Samsung Gear wearables will surface individualized “Health Nudges” that encourage the wearer to perform certain...
June 26, 2019
San Francisco-based digital chronic disease management company Omada Health has closed a $73 million funding round led by Wellington Management Company. Cigna Ventures, Andreessen Horowitz, U.S. Venture Partners, Norwest Venture Partners, Kaiser Permanente Ventures, Sanofi Ventures, Civilization Ventures and Providence Ventures also contributed.
WHAT THEY DO
Omada offers a slew of digital...